U6-shRNA-RFP adenovirus

The U6-shRNA-RFP adenovirus is a recombinant adenovirus serotype 5 designed specifically for experimental control applications in molecular biology and gene therapy research. This vector features specific deletions in the E1 and E3 regions, which are crucial for rendering the virus replication-deficient and enhancing its safety. The U6 promoter drives the expression of a random sequence shRNA, designed as a non-targeting control to rule out off-target effects in RNA interference (RNAi) experiments. This shRNA does not silence any specific gene and therefore serves as a baseline reference. In addition, the adenovirus incorporates a reporter system where the red fluorescent protein (RFP) gene is under the control of a strong cytomegalovirus (CMV) promoter. RFP expression allows for convenient visualization and quantification of transduction efficiency in infected cells or tissues. This dual-function design ensures the delivery of a non-functional shRNA control and reliable fluorescent labeling for tracking viral infection and distribution, making it a valuable tool for validating experimental setups.

The U6-shRNA-RFP adenovirus is widely used as a negative control in gene knockdown experiments across various biological models, including in vitro cell culture and in vivo animal studies. In cultured cells, it helps researchers differentiate between specific gene silencing effects and non-specific outcomes caused by viral transduction or shRNA delivery mechanisms. By providing a random sequence shRNA, it controls for potential cellular stress responses, immune activation, or off-target interactions that might confound RNAi assay results. In animal models, the RFP reporter gene allows for real-time monitoring of viral spread, biodistribution, and persistence within tissues, aiding in the assessment of delivery methods and vector tropism.